Abdominal Bloating. Flatulence
Conditions
Interventions
Intervention 1: Intervention group1: Probiotic recipient. Patients on this group receive Familact probiotic tablets from the Zist-takhmir company, containing 7 strains of bacteria (lactobacilli, bifid
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: All of the Patients with Abdominal Bloating Age between 20 and 50 years Feeling bloated for at least 3 days a month for the last 3 months The first experience of bloating more than 6 months ago
Exclusion criteria
Exclusion criteria: Any history of chronic inflammatory disease or structural disease of the gastrointestinal tract Any serious physical problems or illness, such as inflammation or malignancy Use of calcium channel blockers in the last 3 months Severe stress in the last 6 months Positive family history for Colon Concert History of inflammatory diseases Lactase deficiency disease Celiac disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal Bloadting. Timepoint: Before the start of the study, 2 weeks after the start of the study, 4 weeks after the start of the study, 6 weeks after the start of the study and 8 weeks after the start of the study. Method of measurement: Questionnaire for bloating and IBS-QOL questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Soheilipour
Esfahan University of Medical Sciences
Outcome results
None listed